We are working to sustain our cycle of success into the next decade and beyond by leveraging the scientific expertise we've built in our core disease areas to identify the best science and deliver innovative solutions for patients. said William Hait, M.D., Ph.D., Global Head, Janssen Research & Development, LLC.
and...
With a focus on precision medicine, the company has also invested best-in-class research capabilities in genomics, biotechnology, biomarkers, companion diagnostics, and vaccine platforms, and in accessing early stage breakthrough innovation from the leading innovation hotspots around the world.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)